Home › NDC Lookup › RxCUI directory › RxCUI 859193

Selegiline hydrochloride 5 MG Oral Tablet — RxCUI 859193

RxNorm drug concept · Semantic clinical drug
RxCUI 859193 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI859193
Official nameSelegiline hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asselegiline HCl 5 MG Oral Tablet
FDA products mapped6
Package NDCs mapped7
Reported Medicaid activity (SDUD)930 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Selegiline Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Emsam is a prescription skin patch used to treat major depressive disorder (MDD) in adults. It belongs to a class of antidepressants called MAOIs — monoamine oxidase inhibitors — w...
  • What is the Emsam patch actually used for?
  • It depends on your dose. At the lowest dose, no special diet is required. But at the two higher doses, you do need to avoid foods high in tyramine — things like aged cheeses, cured...
  • Do I really need to avoid certain foods while wearing this patch?
📖 Read our full Selegiline Transdermal Patch guide →

🕸️ Concept Web — How Selegiline hydrochloride 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Selegiline hydrochloride 5 MG Oral Tablet RxCUI 859193

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Selegiline 9639
    • Selegiline hydrochloride 203137
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Anipryl 880384
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Selegiline Oral Tablet 373842
    • Selegiline hydrochloride Oral Tablet 2648721
    • Selegiline Oral Product 1158172
    • Selegiline Pill 1158173
    • Selegiline hydrochloride Oral Product 2659510
    • Selegiline hydrochloride Pill 2662296
    • Selegiline Oral Tablet [Anipryl] 880386
    • Selegiline hydrochloride Oral Tablet [Anipryl] 2655187
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Selegiline hydrochloride 5 MG 859185
    • Selegiline hydrochloride 5 MG Oral Tablet [Anipryl] 897065
    • Selegiline hydrochloride 5 MG [Anipryl] 897064

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Selegiline hydrochloride 5 MG SCDC · 859185
  • Selegiline Oral Tablet SCDF · 373842
  • Selegiline hydrochloride Oral Tablet SCDFP · 2648721
  • Selegiline Oral Product SCDG · 1158172
  • Selegiline Pill SCDG · 1158173
  • Selegiline hydrochloride Oral Product SCDGP · 2659510
  • Selegiline hydrochloride Pill SCDGP · 2662296

Brand-Name Concepts

  • Selegiline hydrochloride 5 MG Oral Tablet [Anipryl] SBD · 897065
  • Selegiline hydrochloride 5 MG [Anipryl] SBDC · 897064
  • Selegiline Oral Tablet [Anipryl] SBDF · 880386
  • Selegiline hydrochloride Oral Tablet [Anipryl] SBDFP · 2655187
  • Anipryl Oral Product SBDG · 1176815
  • Anipryl Pill SBDG · 1176816
  • Anipryl BN · 880384

📦 FDA Products & Package NDCs

6 products · 7 package NDCs
7 package NDCs map to RxCUI 859193 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-2918-00 4 TABLET in 1 BOTTLE (50090-2918-0) Selegiline Hydrochloride A-S Medication Solutions 2017-03-14
60429-0176-60 60 TABLET in 1 BOTTLE (60429-176-60) Selegiline Hydrochloride Golden State Medical Supply, Inc. 2013-04-02
60505-3438-03 60 TABLET in 1 BOTTLE (60505-3438-3) Selegiline Hydrochloride Apotex Corp. 1997-07-06
60505-3438-08 500 TABLET in 1 BOTTLE (60505-3438-8) Selegiline Hydrochloride Apotex Corp. 1997-07-06
62135-0694-60 60 TABLET in 1 BOTTLE (62135-694-60) Selegiline Hydrochloride Chartwell RX, LLC 2024-05-06
72319-0006-02 60 TABLET in 1 BOTTLE (72319-006-02) Selegiline Hydrochloride i3 Pharmaceuticals, LLC 2021-12-15
73141-0006-02 60 TABLET in 1 BOTTLE (73141-006-02) Selegiline Hydrochloride A2A Integrated Pharmaceuticals 2024-03-15
Observed labelers: Apotex Corp. (2) · A-S Medication Solutions (1) · A2A Integrated Pharmaceuticals (1) · Chartwell RX, LLC (1) · Golden State Medical Supply, Inc. (1) · i3 Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.7777
Range $0.7777–$0.7777 · middle 50% $0.7777–$0.7777 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.